VESCHI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 492
EU - Europa 168
AS - Asia 149
AF - Africa 8
Totale 817
Nazione #
US - Stati Uniti d'America 489
SG - Singapore 103
IT - Italia 102
IN - India 26
CN - Cina 18
SE - Svezia 17
IE - Irlanda 12
FI - Finlandia 11
DE - Germania 9
TG - Togo 8
GB - Regno Unito 5
FR - Francia 4
BG - Bulgaria 3
CA - Canada 2
ID - Indonesia 2
RO - Romania 2
UA - Ucraina 2
BE - Belgio 1
MX - Messico 1
Totale 817
Città #
Fairfield 79
Singapore 77
Rome 53
Santa Clara 40
Woodbridge 35
Ashburn 31
Seattle 31
Ann Arbor 25
Chandler 23
Houston 22
Wilmington 22
Dearborn 21
Cambridge 19
Dublin 12
Princeton 10
San Paolo di Civitate 10
Bethesda 9
Lomé 8
Plano 8
Beijing 7
Lawrence 7
Grafing 6
Boardman 5
Fremont 5
Millbury 5
Centrale 4
San Diego 4
Boston 3
Fuzhou 3
Helsinki 3
Milan 3
New York 3
Sofia 3
Andover 2
Buffalo 2
Des Moines 2
Falls Church 2
Hefei 2
Jakarta 2
Kolkata 2
Los Angeles 2
Palermo 2
Redwood City 2
Tremestieri Etneo 2
Valmontone 2
Acton 1
Bremen 1
Brussels 1
Chevy Chase 1
Falkenstein 1
Greenwich 1
Hebei 1
Jinan 1
Kunming 1
Linyi 1
London 1
Mannheim 1
Montréal 1
New Bedfont 1
Palmi 1
Phoenix 1
Prato 1
Pune 1
Redmond 1
Samassi 1
San Benedetto del Tronto 1
Sezze 1
Southend 1
Toronto 1
Washington 1
Yellow Springs 1
Totale 646
Nome #
The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress 115
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1 82
Molecular mechanisms of MYCN-dependent apoptosis and the MDM2-p53 pathway: an Achille's heel to be exploited for the therapy of MYCN-amplified neuroblastoma. 81
Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma 78
Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis 77
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells 69
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors 62
MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response 58
A single-cell transcriptomic analysis of Neuroblastomas revealed a selective cGAS-STING pathway suppression in malignant cells 51
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 26
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 14
Developing selective SETD8 inhibitors for treating high-risk neuroblastoma 13
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 10
Targeting epigenetic alterations in cancer stem cells 8
Meeting the Challenge of Targeting Cancer Stem Cells 8
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis 7
Neuroblastoma epigenetic landscape: drugging opportunities 7
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 7
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment 7
High-SETD8 inactivates p53 in neuroblastoma 6
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy 6
Cancer cell targeting by CAR-T cells: A matter of stemness 6
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 6
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment 6
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2 6
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 5
Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150, decreases neuroblastoma tumorigenicity and increases chemosensitivity 5
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 5
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 5
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells 5
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy 5
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review 4
Whole genome screen to identify genes targeting MYCN-driven embryonal tumors 4
Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150 increases the chemosensitivity and decreases tumor initiating potential of neuroblastoma cells 4
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a therapeutic strategy to reactivate p53 in high-risk neuroblastoma 4
Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options 4
Targeting the chromosomal passenger complex subunit INCENP induces polyploidization, apoptosis, and senescence in neuroblastoma 3
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression 3
Targeting chromosomal passenger complex by disruption of INCENP function inhibits tumor progression in neuroblastoma 3
Targeting MYCN in Pediatric and Adult Cancers 2
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer 2
Totale 879
Categoria #
all - tutte 3.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 20 35 23 16 15 13 11 3
2020/202148 6 3 1 3 3 7 2 2 2 16 3 0
2021/2022101 0 6 13 2 16 2 2 10 3 12 19 16
2022/2023105 15 33 7 5 11 12 0 5 13 1 1 2
2023/2024159 3 6 1 2 9 8 29 17 5 7 42 30
2024/2025158 8 19 29 45 57 0 0 0 0 0 0 0
Totale 879